,000 hospitals through over 3,000 distributors making it the ideal partner to bring NeuroVive's drugs to market in China. Mikael Bronnegard, CEO of NeuroVive Pharmaceutical said: "Our agreement with Sihuan is a transformational event for NeuroVive and provides strong validation of the huge potential of mitochondrial med